SCHEMBL20777977

SCHEMBL20777977

CNn1cc(F)c(=O)[nH]c1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 6/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ MAPK3 P27361 1/20 0.40
▸ ASAH1 Q13510 1/20 0.40
▸ SQOR Q9Y6N5 1/20 0.40
▸ MAPT P10636 2/20 0.40
▸ TSHR P16473 1/20 0.40
▸ PMP22 Q01453 1/20 0.40
▸ HBB P68871 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ GRIA1 P42261 1/20 0.38
▸ GRIA2 P42262 1/20 0.38
▸ GRIA3 P42263 1/20 0.38
▸ GRIA4 P48058 1/20 0.38
▸ GRIK5 Q16478 1/20 0.38
▸ ESR1 P03372 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21284209 0.78 MAPK1 (0.43) LMNAHPGDPOLB
SCHEMBL17278321 0.72 LMNA (0.50) LMNASMN1; SMN2CYP3A4CYP2D6MAPK3
SCHEMBL11741360 0.72 LMNA (0.61) LMNASMN1; SMN2CYP3A4CYP2D6MAPK3
SCHEMBL23240661 0.71 KMT2A (0.37) SMN1; SMN2MAPTKMT2AKDM4ECYP1A2
SCHEMBL28047504 0.70 LMNA (0.44) LMNASMN1; SMN2CYP3A4CYP2D6MAPK3
SCHEMBL12724348 0.69 SMN1; SMN2 (0.43) LMNASMN1; SMN2CYP3A4CYP2D6MAPK3
SCHEMBL22463402 0.68 LMNA (0.41) LMNASMN1; SMN2CYP3A4CYP2D6MAPK3
SCHEMBL18659115 0.68 LMNA (0.41) LMNASMN1; SMN2CYP3A4CYP2D6MAPK3
SCHEMBL11327834 0.68 LMNA (0.41) LMNASMN1; SMN2CYP3A4CYP2D6MAPK3
SCHEMBL13067325 0.68 LMNA (0.42) LMNASMN1; SMN2CYP3A4CYP2D6MAPK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019046511-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF DISEASE SPEROVIE BIOSCIENCES, INC. (US) 2019-03-07 — — WO disclosed
Send feedback